Literature DB >> 26184059

Pituitary apoplexy induced by triptorelin in patient with prostate cancer.

Fernando Guerrero-Pérez1, Agustina Pia Marengo2, Alejandra Planas-Vilaseca2, Vanesa Flores-Escobar3, Carles Villabona-Artero2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26184059     DOI： 10.1016/j.endonu.2015.05.005

Source DB:  PubMed          Journal:  Endocrinol Nutr        ISSN： 1575-0922


× No keyword cloud information.
  5 in total

Review 1.  GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.

Authors:  Francisco J Guarda; Xiaoling Yu; Philip J Saylor; Lisa B Nachtigall; Naila Shiraliyeva; Melanie S Haines; Michael Bradbury
Journal:  Pituitary       Date:  2021-04-09       Impact factor: 4.107

2.  Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.

Authors:  Mariana Barbosa; Sílvia Paredes; Maria João Machado; Rui Almeida; Olinda Marques
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04

3.  Extensive Pituitary Apoplexy after Chemotherapy in a Patient with Metastatic Breast Cancer.

Authors:  Je Hun Jang; Young San Ko; Eun Kyeong Hong; Ho Shin Gwak
Journal:  Brain Tumor Res Treat       Date:  2018-04

4.  Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature.

Authors:  Vanessa Triviño; Olga Fidalgo; Antía Juane; Jorge Pombo; Fernando Cordido
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

5.  Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.

Authors:  Rishi Raj; Ghada Elshimy; Aasems Jacob; P V Akhila Arya; Dileep C Unnikrishnan; Riccardo Correa; Zin W Myint
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-22       Impact factor: 4.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.